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Abstract 
Cardiovascular disease (CVD) is considered to be one of the leading health 
issues in Thailand. CVD not only contributes to an increase in the number of 
hospital admissions year by year but also impacts on the rising health care 
expenditure for the treatment and long-term care of CVD patients. There-
fore, this study is aimed at examining the impacts of risk reduction strate-
gies on the number of CVD hospital admissions, Disability-Adjusted Life 
Years (DALYs) and the costs of hospitalisation. To estimate such impacts a 
CVD cost-offset model was applied using a Microsoft Excel spreadsheet. The 
number of the mid-year population was classified by age, gender and the 
CVD risk factor profiles from the recent Thai National Health Examination 
Survey (NHES) IV. This survey was chosen as the baseline population. The 
CVD risk factor profiles included age, gender, systolic blood pressure, total 
cholesterol, and smoking status. The Asia-Pacific Collaborative Cohort Study 
(APCCS) equation was applied to predict the probability of developing CVD 
over the next eight-year period. Estimates on the following were obtained 
from the model: 1) the CVD events both fatal and non-fatal; 2) the difference 
between the projected number of deaths and the actual number of deaths in 
that population; 3) the number of patients who are expected to live with 
CVD; 4) the DALYs from the estimated number of fatal and non-fatal events; 
5) the cost of hospital admissions. Four CVD risk strategy scenarios were in-
vestigated as follows: 1) the do-nothing scenario; 2) the optimistic scenario; 
3) achieve the UN millennium development goal; and 4) the worst-case sce-
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nario. The findings showed that over the next eight years, there are likely to 
be 3,297,428 recorded cases of CVD; 5,870,049 cases of DALYs; and, ap-
proximately ฿57,000 million, ($1.9 billion), is projected as the total cost of 
hospital admissions. However, if the current health policy can reduce the le-
vels of risk factors as defined in the optimistic scenario or such policy meets 
the specifications of the UN millennium development goal, there would be a 
significant reduction in the number of hospital admissions. These are esti-
mated to be a reduction of 522,179 male and 515,416 female cases. With these 
results, it is expected that health care costs would save approximately ฿9000 
million, ($298.3 million), for CVD and 900,000 million DALYs over the next 
eight years. However, if there is an upward trend in the risk factors as pre-
dicted in the worst-case scenario, then there will be an increase of 428,220 
CVD cases; consequently, DALYs cases may rise by 766,029 while the hospit- 
alisation costs may increase by approximately ฿7000 million, ($232.1 mil-
lion). Based on our findings, reducing the levels of CVD risk factors in the 
population will drastically reduce: 1) the number of CVD cases; 2) DALYs 
cases; and 3) health care costs. Therefore it is recommended that the health 
policy should enhance the primary prevention programs which would be tar-
geted at reducing the CVD risk factors in the population.  
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1. Introduction 
CVD is considered one of the main potential health care problems in Thailand. 
The burden of the disease and related injuries from a study in Thailand esti-
mated that 1,146,064 DALYs were lost from CVD, which includes both ischemic 
heart diseases (IHD) and stroke [1]. The DALYs lost from stroke was ranked as 
the third-highest in men and the second highest in women, whereas, IHD was 
rated as the sixth and fourth highest cause of death and disability in men and 
women, respectively. Although the overall mortality rate in Thailand has re-
duced over the past decade due to improvements in the health care services, the 
prevalence of CVD, however, continues to rise [2]; this has led to an increasing 
need for medical and long term care for CVD patients. Consequently, CVD has 
become a burden for both patients and the health service providers in terms of 
health care expenditure.  
The increase in the prevalence of CVD is related to socio-economic and life-
style changes in the population in Thailand which have increased the risk of 
CVD [3] [4]. It has been proved that classical CVD risk factors such as high 
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blood pressure, high total cholesterol and cigarette smoking are related to the 
incidence of CVD [5] [6] [7] [8]. The Ministry of Public Health, Thailand has 
encouraged the reduction of these modifiable risk factors at the population level. 
Many public health interventions have been implemented, such as health educa-
tion, advocating physical activity, promoting healthy diets and changing the 
smoking regulations [9]. However, this raises the following questions: will the 
investment in public health programs reduce the further demand for health care 
in the population; and, if so, how much benefit will be gained from reducing the 
risk factors at the population level? 
In terms of CVD modelling, several studies have projected the number of fu-
ture CVD events and health care expenditure for the country, based on the cur-
rent information of the risk factors levels in the population [10] [11] [12]. Some 
studies have found that reducing the level of risk factors in the population will 
subsequently reduce the number of deaths and disability from CVD, and at the 
same time help to save on the costs of hospital admissions [13] [14] [15]. Many 
studies in the health economics field have investigated the cost-effectiveness of 
secondary prevention programs and treatment strategies, such as comparing the 
multidrug regimen for prevention of CVD [16]-[20], coronary artery revascula-
rization procedures [21], and the treatment of high blood pressure [22]. 
This study; however, focuses on the primary prevention strategies that should 
be implemented within the general population, to prevent them from being ad-
mitted into the hospital due to CVD. The study aims to estimate the impact of 
public health risk reduction strategies on the potential benefits of this invest-
ment. The mathematical model conducted assessed the modified risk equation 
from the Asia Pacific Cohort [2] study collaboration. The eight-year probability 
of CVD events has been calculated based on the most recent population-level 
risk factors information. The model estimates the number of patients living with 
CVD conditions, such as IHD and stroke; and those with the burden of the 
DALYs diseases that are likely to be admitted into the hospital. The outcomes of 
interest in this study are the impacts in terms of the number of CVD hospital 
admissions avoided, the DALYs saving and the health care financial savings. 
2. Materials and Methods 
2.1. The CVD Cost-Offset Model 
A CVD cost-offset model [16] has been applied to: 1) Estimate the number of 
CVD hospital admissions during the next eight-year period; 2) Predict the bur-
den of disease in terms of DALYs; and 3) Estimate the cost of hospital admis-
sions due to CVD conditions. The CVD cost-offset model was used to assess the 
impact of risk reduction strategies on the number of hospital admissions, DALYs 
and direct health care costs. The effects of changing the risk factors at the popu-
lation level have been investigated through four different scenarios. The analysis 
process is described below. 
The CVD cost-offset model was computed using a Microsoft Excel spread-
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sheet. The baseline population size was defined by the most recent relevant data 
available which included gender and age group information. The CVD risk fac-
tors such as age, systolic blood pressure, total cholesterol, and regular smoking 
obtained from the Thai 4th National Health Examination Survey (NHES) IV [2] 
[23], were used as the input parameters to represent the mean level of risk fac-
tors within the Thai population and identified by age group and gender. Table 1 
shows the input data of the cost-offset model based on the number of the 
mid-year population and the risk factor profiles.  
The probability of experiencing CVD events within an eight-year period was 
obtained using the Asia-Pacific Cohort Study (APCS) equations [4]. Age, systolic 
blood pressure, total cholesterol and smoking were included as risk factors in the 
equation. From the model, the probability of CVD events within an eight-year 
period was estimated by age group and gender. Then, the eight-year probability 
of CVD events was multiplied by the number of the mid-year population to get 
the estimated number of CVD events over the next eight years. However, the 
APCS equation calculated the probability of all CVD events, which included 
both fatal and non-fatal CVD events. 
 
Table 1. The number of the mid-year population and the mean level of risk factors by age 
group and gender in 2009. Thai 4th national health examination survey. 
Men 
Mid-year 
population 
2009 
The mean level of risk factors 
Age 
(years) 
SBP 
(mmHg) 
TC 
(mmol) 
Smoking 
prevalence (%) 
15 - 24 4,683,981 18.76 117.24 4.60 28.5% 
25 - 34 5,149,508 29.92 120.80 5.27 42.3% 
35 - 44 5,154,963 39.75 122.56 5.43 39.9% 
45 - 54 4,058,120 49.33 126.44 5.46 42.6% 
55 - 64 2,399,309 60.11 131.44 5.40 34.4% 
65 - 74 1,362,752 69.17 134.60 5.31 30.5% 
≥75 749,125 79.22 137.22 5.20 23.5% 
Total 23,557,758 52.80 128.39 5.28 34.0% 
Women 
Mid-year 
population 
2009 
The mean level of risk factors 
Age 
(years) 
SBP 
(mmHg) 
TC 
(mmol) 
Smoking 
prevalence (%) 
15 - 24 4,532,018 18.97 106.19 4.90 0.7% 
25 - 34 5,130,746 29.87 110.19 5.21 1.4% 
35 - 44 5,408,488 39.65 116.04 5.30 1.8% 
45 - 54 4,388,770 49.10 123.92 5.70 2.6% 
55 - 64 2,694,633 60.02 129.45 5.92 3.0% 
65 - 74 1,655,159 69.24 134.53 5.80 3.5% 
≥75 1,086,374 79.48 139.19 5.66 5.2% 
Total 24,896,188 52.60 124.70 5.58 3.0% 
R. Inthavong et al. 
 
 
DOI: 10.4236/oalib.1106160 5 Open Access Library Journal 
 
The number of CVD events which caused mortality was estimated using the 
average 10-year probability of dying from CVD in the general Thai population 
from 1996 to 2006, classified by age and gender. The likelihood of dying from 
CVD is shown in (Table A1 & Table A2). The number of people who are likely 
to die from CVD was estimated by multiplying the number of estimated CVD 
events with the probability of dying from CVD. Then, the model deducted the 
number of people who are likely to die from CVD to obtain the number of 
people who will be alive with CVD conditions. The outcomes of interest are the 
number of people with CVD who are alive and the number of deaths from CVD 
conditions over the eight-year period.  
2.2. Disability Adjusted Life Years (DALYs) 
Once the model had estimated the number of CVD events over an eight-year pe-
riod, the total DALYs for each age group and gender were calculated as the 
summation of the years lost due to disability, (YLD), and the years of life lost 
due to premature death (YLL). Therefore, DALYs will present the burden of 
CVD which includes both the non-fatal burden and the burden of premature 
death. The calculation procedure follows the WHO national burden of disease 
studies [24].  
DALY YLD YLL= +                      (1) 
where: YLD = number of years lost due to disability. 
YLL = Number of years of life lost due to premature death. 
2.3. Discounting and Age Weighting 
It is standard practice for a health economic analysis to discount future benefits 
[25]. This study has applied a 3% discount rate to years of life lost in the future, 
to estimate the net present value of years of life lost and for adjusting both future 
costs and health outcomes as recommended in the Global Burden of Disease 
study project [26] and the burden of disease study project in Thailand [27]. The 
assumption of using the age weight was based on the social preference which 
values a year of life in a younger adult higher than that of a year lived by some-
one in an elderly age group because the younger adult is considered as being in 
the labour force which has a more economic productivity value than the elderly 
age group.  
2.4. Calculating YLL 
YLL represents the number of years of life lost due to premature death which is 
calculated by multiplying the number of deaths with the standard life expectan-
cies in each age-gender group.  
YLL N L= ×                          (2) 
where: N = number of deaths and L = Standard life expectancy at age of death in 
years. 
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The estimated number of deaths in each age group was entered into the 
spreadsheet to calculate YLL. The average age at death for each age group was 
calculated by using the mid-point of age at death in each age interval. Then, the 
standard life expectancies of these average age at death was calculated by inter-
polation between the standard life expectancies at the exact ages of death given 
from the West standard life tables [28] by the single year of age.  
With a 3% discounting and uniform age weights; YLL was computed using the 
formula:  
( )0.03LYLL 1 e0.03
N −= −                     (3) 
where: N = number of deaths; and L = Standard life expectancy at age of death in 
years taking into account the 3% discount rate and age weight. 
2.5. Calculating YLD 
YLD presents the years lost due to disability which is the main component of 
DALYs. The basic formula of YLD is: 
YLD I DW L= × ×                       (4) 
where: I = the number of incidence cases in the reference period. 
DW = the disability weight. 
L = the average duration of disability in years. 
In this analysis, the estimated number of people who are alive with CVD con-
ditions by age and gender was entered into the spreadsheet as the number of in-
cidence cases occurring during the eight-year period (I). The disability weight 
that was used as the average disability weight was from the GBD study underta-
ken in 2010 and was set at 0.18 for all CVD conditions. 
The disability weight by CVD conditions of the GBD study is shown in Table 
A3. The average age onset of the disability and the duration of disability was 
calculated by using DISMOD II software [29]. 
DISMOD II software was developed by Jan J Barendregt, Department of Pub-
lic Health of Erasmus University, Netherlands [30]. This software developed so-
phisticated methods to measure the causes and patterns of disease in populations 
and was used as an analytical tool in the GBD study to check the consistency of 
various data and for estimating the incidence, prevalence, duration and, fatality 
events. DISMODII has been commonly used in YLD calculations for estimating 
the incidence and duration of the disease from information available about a 
country. An underlying generic disease model concept has been developed in 
DISMOD software to explore the causal relationships and the disease process as 
shown in Figure 1. 
The number of the mid-year population, the background mortality, the pre-
valence of CVD and the CVD mortality rate in the Thai population classified by 
age and gender has been entered as the input information into the DISMOD 
software. This analysis assumed the remission rate from CVD is equal to zero.  
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Figure 1. Conceptual generic disease model in DISMOD software (Barendregt et al., 
2003). 
 
The study estimated the onset of getting CVD and the duration of the disability 
from CVD by age and gender.  
2.6. Health Care Cost for CVD Patients 
The average total cost of hospital admissions from CVD was calculated from the 
inpatient services in Thailand. The costing data obtained from the national health 
security office includes the universal coverage health care scheme. The results of 
the health care costs were as reported in [31]. The health care service providers 
spent ฿32,884, ($1090.3), per patient on IHD, ฿25,618, ($849.6), per patient on 
strokes and ฿21,921, ($726.9), per patient on all CVD conditions. Because of the 
limitations of the APCS equation, which estimates the total CVD incidence only, 
the average cost of all CVD conditions has been used to estimate the total health 
care costs for the next eight years. The estimated total health care cost was com-
puted by multiplying the average cost per patient with the estimated number of 
CVD cases. However, this analysis is based on 2009 prices; therefore the dis-
count rate has been applied to these costs to estimate the present value of the 
health care expenditure. 
2.7. Impact of Changing CVD Risk Factors 
The model was used to consider the CVD risk reduction scenarios which tar-
geted the following three CVD risk factors; systolic blood pressure, total choles-
terol, and prevalence of smoking at the population level. Some of the underlying 
assumptions of the CVD cost offset analysis include: 1) the population structure 
and the health care system remaining unchanged from those of 2009; 2) no 
change in the population figure, classified by age group and gender over time; 
and 3) the mean age for the respective age groups remains the same as in the 
model. From the model, we estimated the impact of changing the risk factors on 
the number of CVD patients, the number of DALYs, and the cost of hospitalisation 
in four different scenarios. Table 2 shows a summary of changing the percen-
tages of the risk factors against those scenarios. 
The grouping for different scenarios analysed in this study was as follows:  
R. Inthavong et al. 
 
 
DOI: 10.4236/oalib.1106160 8 Open Access Library Journal 
 
Table 2. Summary of the risk reduction scenarios for the CVD cost-offset model. 
Scenario 
% Change of the risk factors level 
Systolic blood 
pressure 
Total 
Cholesterol 
Smoking 
1) Do nothing scenario 0% 0% 0% 
2) The optimistic scenario −5% −5% −5% 
3) Reach the UN millennium development goal −5% 0% −30% 
4) The worst case scenario +3.35% +11.7% −30% 
 
1) Do nothing scenario: this scenario assumes that there is no change in CVD 
risk factors over time. The level of CVD risk factors remains the same.  
2) The optimistic scenario: this scenario assumes that all CVD risk factors 
have been reduced in the population through public health initiative strategies. 
The target risk factors have been reduced by 5%.  
3) Reach the UN millennium development goal; this scenario estimates what 
will happen if the risk reduction strategies in Thailand can achieve the UN mil-
lennium development goals. The goals’ main target is to reduce 25% of the glob-
al premature mortality from non-communicable disease (NCDs) based on the 
2010 levels and to achieve it by 2025 [32]; the goal, referred to by some studies as 
the “25 × 25” target [33]. The target risk reductions are a reduction of 30% in the 
prevalence of tobacco smoking; reducing alcohol consumption by 10%. The re-
duction of 30% in the average salt intake of the population, prevents the rising 
incidence of obesity, reduces 25% of the prevalence of high blood pressure and 
stops the rise in the prevalence of diabetes. Based on the available information 
for the model, this scenario analysis is targeted at reducing 30% of the smoking 
rate and assumed that the level of systolic blood pressure stroke is reduced by 5% 
to achieve this goal, and the other risk factors remain the same.  
4) The worst-case scenario: This scenario assumes that the trend of risk fac-
tors in the population will be changed according to the information provided by 
the WHO global observatory, Thailand’s country profile data [34]. The trends of 
the risk factors of the Thai population who are aged 25 years and, over have been 
presented in (Tables A4-A6). 
From 1980 to 2009, there was a +3.35% increase in the level of systolic blood 
pressure in the population and +11.7% increase in the total cholesterol level. 
Meanwhile, the population smoking rate reduced by 30% because of the effec-
tiveness of the smoking regulation policy in Thailand [35]. 
3. Results 
3.1. The Estimated Number of CVD Patients over an 8 Year Period 
Table 3 shows the estimated number of CVD patients over the next eight years 
by age group, gender and risk reduction scenarios. The model estimates the 
highest number of patients appear in the “worst-case scenario” which is 
3,725,649 patients and the second-highest figure is in the “do nothing scenario”  
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Table 3. Estimated number of CVD patients over an eight-year period at different scenarios. 
Conditions Age group 15 - 24 25 - 34 35 - 44 45 - 54 55 - 64 65 - 74 ≥75 Total 
Do nothing 
scenario 
Men 6617 16,168 4658 94,021 31,198 589,000 545,177 1,609,550 
Women 3662 10,240 38,912 93,534 300,332 586,461 654,736 1,687,878 
Total 10,279 26,409 85,491 187,555 612,320 1,175,461 1,199,913 3,297,428 
Optimistic 
scenario 
Men 5502 13,311 38,269 76,909 254,802 482,299 450,836 1,321,927 
Women 3220 8959 33,821 80,592 257,736 503,081 565,912 1,453,321 
Total 8721 22,270 72,090 157,501 512,538 985,380 1,016,749 2,775,249 
Reaching UN 
millennium 
goal 
Men 5492 13,181 37,999 76,213 254,127 482,308 453,004 1,322,324 
Women 3239 9013 34,016 81,045 259,161 505,518 567,697 1,459,688 
Total 8732 22,193 72,016 157,258 513,287 987,826 1,020,700 2,782,012 
Worst 
case 
scenario 
Men 7522 18,315 53,043 107,066 358,514 677,311 625,333 1,847,104 
Women 4033 11,316 43,173 104,367 335,897 655,003 724,758 1,878,546 
Total 11,555 29,630 96,215 211,433 694,411 1,332,314 1,350,091 3,725,649 
 
which is 3,297,428 patients. However, if public health interventions lead to a re-
duction in the risk factor levels of CVD, as it is anticipated in the “optimistic 
scenario”, the estimated number of CVD patients will consequently reduce to 
2,755,249 patients. Additionally, if the health policies achieve the UN Millen-
nium development goal, the number of total CVD patients will decrease to 
2,782,012 patients.  
When comparing the estimated number between men and women by age 
group and the risk reduction scenarios; overall, the model predicts the number 
of CVD patients would be higher amongst women than men. However, the UN 
millennium goal scenario estimated the number of male CVD patients to be 
higher than the figures for women in most age groups except at age 75 years and 
over. This might be because reducing cigarette smoking by 30%, could have a 
higher impact on men as they have a higher prevalence of regular smoking than 
women (Table A2). When comparing the total estimated number of CVD pa-
tients by age group and the risk reduction scenarios, the estimated number of 
CVD patients increases respectively, with the increase in age in both men and 
women. The worst-case scenario estimated the highest number of CVD patients, 
followed by the do-nothing scenario. The optimistic scenario and reaching the 
UN millennium development goal estimated nearly the same reduction in the 
number of patients (Table A1). 
3.2. The Estimated DALYs over 8 Year Period 
Table 4 shows the estimation of the absolute total DALYs and DALYs lost 
from CVD per 1000 populations over the next eight years by age group gender 
and the risk reduction of different scenarios. The highest DALYs overall is in 
the worst-case scenario, which has a total loss of 6,636,078 DALYs. The second 
highest is in the do-nothing scenario which has a total loss of 5,870,049 DALYs.  
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Table 4. The estimated absolute total DALYs over an eight-year period within the different scenarios. 
Age 
Do nothing scenario Optimistic scenario 
Reaching the 
UN millennium goal 
Worst case scenario 
Men Women Total Men Women Total Men Women Total Men Women Total 
15 - 24 6671 6262 12,932 5546 5505 11,052 5537 5539 11,076 7583 6896 14,479 
25 - 34 24,581 24,124 48,706 20,237 21,106 41,343 20,039 21,232 41,271 27,844 26,657 54,502 
35 - 44 95,837 104,830 200,667 78,738 91,115 169,853 78,184 91,641 169,825 109,135 116,309 225,444 
45 - 54 224,123 244,975 469,098 183,333 211,079 394,412 181,674 212,265 393,938 255,221 273,346 528,566 
55 - 64 720,474 698,020 1,418,494 588,415 599,018 1,187,433 586,855 602,330 1,189,186 827,917 780,677 1,608,594 
65 -74 1,124,054 1,093,675 2,217,730 920,424 938,183 1,858,607 920,442 942,727 1,863,169 1,292,588 1,221,498 2,514,086 
≥75 681,299 821,122 1,502,421 563,403 709,726 1,273,129 566,112 711,963 1,278,075 781,469 908,938 1,690,407 
Total 2,877,040 2,993,009 5,870,049 2,360,096 2,575,732 4,935,828 2,358,842 2,587,697 4,946,540 3,301,757 3,334,322 6,636,078 
 
Further, when the model assumed that the CVD risk factors had been reduced, 
as in the optimistic scenario, the total DALYs lost will be reduced to 4,935,828 
DALYs. Moreover, if the model assumed that CVD risk factors could be reduced 
as in the UN millennium goal scenario, the total DALYs lost will be reduced to 
4,946,540. Both the optimistic scenario and the UN millennium goal scenarios 
estimated the DALYs as nearly the same.  
When comparing DALYs across the age groups, it was found that the number 
of DALYs lost from CVD increases respectively with an increase in the age 
group. The DALYs figure is higher in older adults, (age 35 years and older) than 
in younger adults (ages 15 to 34). The absolute total DALYs is highest at ages 65 
to 74 years across the four scenarios (1,199,375, 1,003,599, 1,006,104, 1,360,930, 
respectively).  
Table 5 presents the summary results of the CVD cost-offset model compared 
against the four scenarios analyses and the impact of changing CVD risk factors, 
on the number of CVD hospital admissions, total costs of hospitalisation and the 
DALYs. The do-nothing scenario in the model estimated that over the next 
eight-year period there will be 3,297,428 CVD patients if the levels of risk factors 
remain the same. However, if the levels of risk factors are reduced as in the op-
timistic scenario, (all risk factors reduce by 5%), it will reduce the number of 
CVD hospital admissions by 522,179 people. Additionally, if health interven-
tions can achieve the UN millennium development goal, there will be a reduc-
tion in the number of CVD hospital admissions by 515,416 people. Conversely, 
if the trend of risk factors increases amongst the population as in the worst-case 
scenario, the number of CVD hospital admissions is estimated to be 3,725,649 
representing an increase of 428,220 CVD patients. 
In terms of the total cost of hospitalisation, when applying the discount rate of 
3%, it is estimated that health service providers would spend ฿57.1 thousand 
million, ($1.9 thousand million), on medical expenditure for CVD patients over 
the next eight-year period. However, if the health interventions can reduce the  
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Table 5. Summary of the CVD cost-offset model showing the four different scenarios. 
Conditions 
Scenario 
1) Do nothing 
scenario 
2) Optimistic 
scenario 
3) Archive the UN millennium 
development goal 
4) Worst case 
scenario 
Number of CVD patients 3,297,428 2,775,249 2,782,012 3,725,649 
Number of CVD hospital 
admission saving, compare to 
“Do nothing scenario” 
−ref 522,179 (saving) 515,416 (saving) 428,220 (increase) 
Total cost (THB) 72,282,962,149 60,836,250,852 60,984,521,378 81,669,994,287 
Total cost (THB) of hospitalization 
with 3% Discount rate 
57,060,837,804 48,024,698,204 48,141,744,326 64,471,047,657 
Cost of hospitalisation saving (THB) −ref 9,036,139,600 (saving) 8,919,039,478 (saving) 7,410,209,853 (increase) 
Total DALYs (years) 5,870,049 4,935,828 4,946,540 6,636,078 
DALYs saving (years) −ref 934,221 (saving) 923,509 (saving) 766,029 (increase) 
 
levels of risk factors as in the optimistic scenario, there will be a ฿9036 million, 
($299.6 million), saving on the hospitalisation costs. In addition, if the health 
policy can achieve the UN millennium development goal, it will save ฿8919 mil-
lion, ($295.8 million), on health care expenditure. Conversely, if the trend of 
CVD risk factors continually increases as in the worst-case scenario, the health 
care expenditure will increase by ฿7410 million, ($245.7 million), over the next 8 
year period.  
Furthermore, the cost offset model estimated that 5,870,049 DALYs would be 
lost due to CVD in Thailand over the next eight years if the levels of risk factors 
remain the same as in 2009. However, the government would be able to save 
934,221 DALYs if all levels of risk factors could be reduced as in the optimistic 
scenario. Moreover, if the health policy can reach the UN millennium develop-
ment target, there will be 923,509 DALYs saving in the next eight years. Or, if 
the trend of CVD risk factors continuously increases as in the worst-case scena-
rio, the total DALYs will increase to 6,636,078 DALYs during the next eight-year 
period, which would be an increase of 766,029 DALYs overall, in the Thai popu-
lation. 
4. Discussion 
In 2012 there were 327,435 CVD patient admissions to hospitals with a total 
health care expenditure of about ฿7177 million, ($238 million). With regard to 
the burden of disease (BOD), the estimated total DALYs of IHD and Stroke to-
gether were 1,146,064 DALYs in 2012 [9]. If the levels of CVD risk factors re-
main the same, the number of CVD patients will increase approximately 10 fold 
and the total DALYs of CVD will increase to 5,870,049 DALYs over the next 
eight-year period. However, if the trend of risk factors increases as in the 
worst-case scenario, the number of CVD patients will significantly increase 
(Table 3 and Table 5). As a consequence, the health care expenditure will also 
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increase as well as the DALYs increasing (Table 4 and Table 5). 
The CVD cost off-set model has estimated that there are potential benefits of 
reducing the CVD risk factors at the population level. The optimistic risk reduc-
tion scenario and reaching the UN millennium goal scenario are both estimated 
to have the potential benefit of reducing CVD risk factors on the number of 
CVD hospitalisations avoided, the total cost of hospital admissions savings and 
the DALYs saving. Both these scenarios demonstrate similar savings although 
the UN millennium goal does not take into account the reduction of total cho-
lesterol, there are still high impacts on reducing the level of systolic blood pres-
sure and reducing the prevalence of smoking.  
In terms of the DALYs estimation, the DALYs calculation incorporated an age 
weight which considers the value of the years of life lost at an elderly age to be 
less than in younger adults. The use of age-weighting is controversial because the 
societal perspective is concerned about economic productivity, and the value of 
the years of life are weighted differently among age groups. Nonetheless, from an 
equality perspective, the values of the years of life are weighted equally for all age 
groups. However, the applied model in this research is flexible enough to esti-
mate DALYs with or without using age-weighting. When applying age weights 
in the analysis, it was found that DALYs in the younger age group, (15 - 34) had 
increased and DALYs in the older age group had decreased. 
Additionally, this analysis used the standard life-table, with West Level 26 to 
calculate the life expectancy in the population. Following the global burden of 
disease (GBD) and BOD studies, conducted in Thailand, such standard life table 
was adopted, as against the country’s life table, for comparing the results with 
the other studies. However, the DALYs estimation in this study used the recent 
Thailand specific life table in 2012 in its’ calculations. When applying the coun-
try-specific life table to calculate DALYs, it was found that the number of 
DALYs lost was slightly lower, compared to the standard life table. This is be-
cause the standard life table has a higher life expectancy at birth than in the 
Thailand life table. The life expectancy at birth, according to the standard life ta-
ble is 80 years in men and 82.5 years in women. While the life expectancy at 
birth in the Thailand life table in 2012 is 71 years in men and 79 years in women. 
4.1. The Strength of the Study 
This study provides information for the health policy developers to plan and in-
vest in primary prevention programs for chronic diseases such as CVD, rather 
than waiting until the problems occur. In terms of the implications for policy 
and practice in Thailand, some primary interventions have already been suc-
cessfully implemented, such as the smoking regulations which have reduced the 
prevalence of smoking in the Thai population over the last decade [36]. Howev-
er, some primary prevention programs such as promoting a healthy diet and 
undertaking physical activity were not evaluated with respect to their impact on 
reducing the risk factors of CVD or whether CVD has increased within the pop-
ulation. This is because CVD is caused by a combination of risk factors and it is 
R. Inthavong et al. 
 
 
DOI: 10.4236/oalib.1106160 13 Open Access Library Journal 
 
difficult to measure the impact on the health benefits over a short-term period. 
The CVD cost-offset model can be used as a financial tool in helping to develop 
the health policy for long-term planning and targeting the investment in prima-
ry prevention programs for reducing the instances of CVD. The findings in this 
study show that there will be significant benefits of reducing the CVD risk fac-
tors by reducing the number of hospitalisations, reduction of the burden of dis-
ease (DALYs) and savings on the future health care expenditure. 
Additionally, the CVD cost-offset model that has been developed in this study 
used the APCS equation as the risk engine to calculate the probability of in-
stances of CVD events during the eight-year period. The APCS equation is 
generalisable for applying to other Asian populations because it was derived 
from the pools of data from cohort studies around Asia. Therefore, this model 
is able to be replicated and applied to other settings in Asian countries, if the 
essential information of the population data and the risk factors profiles are 
available. 
4.2. Limitations of the Study 
There are some limitations to the CVD cost-offset model. The first limitation is 
that the modelling was conducted under limited conditions with some underly-
ing assumptions. The model is static and compares the estimation at two points 
of time from 2009 and over the next 8 year period. The model assumed that the 
number and population structure by age group and gender remains the same, 
but the reality is that people in the cohort will age. Several studies have suggested 
that Thailand will become an aging society by 2050 because of the falling fertility 
rate in the Thai population [36]. It was estimated that in a few decades, Thailand 
will, for the first time, have a greater population aged 60 years and over than the 
population aged less than 15 years old [37]. Therefore, the population structure 
in the future may be different from now because there may be more people in 
the elderly age groups.  
Secondly, CVD risk factors are modifiable. Some risk factors might vary with 
the age difference and can change over time. Younger adults and older adults 
experience different levels of risk factors. For example, older adults may expe-
rience high blood pressure more than younger adults. Some behavioural risk 
factors are dynamic which may change anytime based on individual behaviours, 
such as cigarette smoking. This model was not able to capture any dynamic 
changing of the CVD risk factors of the individual because the estimation was 
based on the mean level of risk factors by each age group and gender.  
Lastly, the model uses the APCS equation to calculate the eight-year probabil-
ity of acquiring CVD. This equation has some limitations in terms of the num-
ber of independent variables, such as age, gender, systolic blood pressure, total 
cholesterol level and cigarette smoking status. Some potential risk factors such as 
diabetic status and BMI level were not included in the equation, which may have 
the effect of underestimating the risk of CVD in people who have a high BMI or 
diabetes. Furthermore, although the equation can estimate the overall probabili-
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ty of acquiring CVD, it lacks the capacity to determine the probability of specific 
CVD conditions, such as stroke and IHD, separately. However, this equation is 
suitable for use within Asian populations. It has been validated in the perfor-
mance of the equations within the Thai cohort [4] and also in this study [38]. 
The model could perform a more precise estimation if the country-specific CVD 
risk assessment equations were available. 
5. Conclusions 
Findings from this study suggest that reducing any combination of the CVD risk 
factors can reduce instances of acquiring CVD in a healthy population, as well as 
savings in the burden of disease in terms of DALYs and savings on health care 
expenditure.  
If the public health initiatives could either attain the UN millennium devel-
opment goal or a reduction of 5% in the CVD’s risk factors, the health service 
provider would be able to save approximately ฿9000 million, ($298.4 million), 
and about 900,000 DALYs over the next eight years. 
On the other hand, if the trend of risk factors increases, there will be an in-
crease in health care expenditure of ฿7400 million, ($245.3 million) and an in-
crease of 766,029 DALYs during the eight-year period. The modelling which was 
used in this study [16] presented the benefits of investment in primary preven-
tion, which could prevent the number of deaths and also reduce the number of 
hospital admissions as well as saving costs of acute hospital admissions from 
CVD in the UK. 
6. Future Work 
This study contributes to the initial CVD cost-offset model for estimating the 
future burden of CVD events and the future potential benefits of reducing the 
risk factors of CVD in the population level in Thailand. A more sophisticated 
and dynamic model can be developed by applying the Markov model or Discrete 
event simulation model if the specific CVD risk equations and the data are 
available. The dynamics of the risk factors should be taken into account in any 
further study because in reality most CVD risk factors are modifiable and can 
change over time when people change their health behaviour. 
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Appendix 
The probability of death in the Thai population from 1996 to 2006. The probability of death from CVD has been cal-
culated from the number of death from CVD divided by the number of mid-year population each year and classified 
by age group and gender. 
 
Table A1. Probability of dying from all CVD (1996-2006) in the Thai population. 
Age 
1996 1997 1998 
Male Female Total Male Female Total Male Female Total 
15 - 24 0.000398794 0.000145262 0.000274213 0.00036604 0.000146244 0.000257992 0.000230343 0.000126603 0.000179248 
25 - 34 0.000952812 0.000281999 0.000621294 0.000980456 0.000315141 0.000651967 0.000901672 0.000302012 0.000605674 
35 - 44 0.001253676 0.000474107 0.000862295 0.001215292 0.000431124 0.000821186 0.00108842 0.000411782 0.000747959 
45 - 54 0.002050223 0.001055035 0.001541176 0.001852103 0.001019558 0.00142603 0.001697635 0.000906511 0.001292959 
55 - 64 0.003771456 0.002187529 0.002943464 0.003329804 0.00209481 0.002683261 0.003036482 0.001847158 0.002413529 
65 - 74 0.006341359 0.004154046 0.005176651 0.005541879 0.003706673 0.004559946 0.004817827 0.0034094 0.004061503 
75+ 0.011155654 0.008667278 0.009715244 0.009550196 0.007534551 0.00838527 0.008421561 0.006909529 0.007547073 
total 0.001701233 0.00098959 0.001342764 0.001569198 0.000931843 0.001247898 0.00139975 0.000858852 0.001126749 
Age 
1999 2000 2001 
Male Female Total Male Female Total Male Female Total 
15 - 24 0.000150838 0.000080 0.000116 0.000089 0.000050 0.000070 0.000087 0.000040 0.000064 
25 - 34 0.000538701 0.000203 0.000373 0.000285 0.000132 0.000210 0.000217 0.000104 0.000161 
35 - 44 0.000761657 0.000323 0.000541 0.000505 0.000215 0.000359 0.000458 0.000217 0.000336 
45 - 54 0.001253283 0.000725 0.000983 0.000987 0.000544 0.000761 0.000995 0.000577 0.000781 
55 - 64 0.002425317 0.001486 0.001932 0.001882 0.001116 0.001480 0.001972 0.001176 0.001553 
65 - 74 0.004232015 0.003004 0.003571 0.003468 0.002462 0.002926 0.003689 0.002654 0.003129 
75+ 0.007553248 0.006001 0.006660 0.006353 0.005300 0.005748 0.007603 0.006748 0.007110 
total 0.001077724 0.000710 0.000892 0.000815 0.000562 0.000687 0.000842 0.000623 0.000731 
Age 
2002 2003 2004 
Male Female Total Male Female Total Male Female Total 
15 - 24 0.000079 0.000033 0.000057 0.000115 0.000036 0.000076 0.000107 0.000034 0.000071 
25 - 34 0.000159 0.000070 0.000114 0.000154 0.000060 0.000108 0.000183 0.000069 0.000126 
35 - 44 0.000355 0.000163 0.000257 0.000372 0.000158 0.000264 0.000421 0.000178 0.000297 
45 - 54 0.000886 0.000474 0.000674 0.000771 0.000432 0.000597 0.001046 0.000544 0.000786 
55 - 64 0.001825 0.001173 0.001484 0.001650 0.000982 0.001304 0.002217 0.001309 0.001741 
65 - 74 0.003489 0.002424 0.002908 0.003144 0.002413 0.002755 0.004192 0.002894 0.003483 
75+ 0.005880 0.005070 0.005406 0.004198 0.003873 0.004013 0.006670 0.005648 0.006071 
total 0.000765 0.000569 0.000665 0.000833 0.000635 0.000733 0.000939 0.000669 0.000801 
Age 
2005 2006    
Male Female Total Male Female Total    
15 - 24 0.000088 0.000030 0.000060 0.000064 0.000030 0.000047    
25 - 34 0.000151 0.000065 0.000108 0.000128 0.000052 0.000090    
35 - 44 0.000386 0.000149 0.000265 0.000327 0.000137 0.000230    
45 - 54 0.000993 0.000458 0.000716 0.000854 0.000404 0.000620    
55 - 64 0.002028 0.001128 0.001555 0.001815 0.001011 0.001392    
65 - 74 0.003708 0.002650 0.003129 0.003411 0.002417 0.002867    
75+ 0.006318 0.005688 0.005948 0.006099 0.005147 0.005540    
total 0.000870 0.000625 0.000745 0.000797 0.000576 0.000684    
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Table A2. Showing the average 10-year probability of dying from CVD classified by age group and gender. 
Age 
Average 10-years probabilities 
Male Female Total 
15 - 24 0.0001615 0.0000682 0.0001157 
25 - 34 0.0004228 0.0001504 0.0002881 
35 - 44 0.0006494 0.0002597 0.0004527 
45 - 54 0.0012168 0.0006489 0.0009253 
55 - 64 0.0023593 0.0014100 0.0018620 
65 - 74 0.0041849 0.0029262 0.0035060 
75+ 0.0072546 0.0060533 0.0065584 
total 0.0010553 0.0007045 0.0008777 
 
Table A3. The disability weight of the cardiovascular disease from GBD study 2010. 
Cardiovascular and circulatory disease Estimate 95% CI 
Acute myocardial infarction: days 1 - 2 0.422 0.284 - 0.566 
Acute myocardial infarction: days 3 - 28 0.056 0.035 - 0.082 
Angina pectoris: mild 0.037 0.022 - 0.058 
Angina pectoris: moderate 0.066 0.043 - 0.095 
Angina pectoris: severe 0.167 0.109 - 0.234 
Cardiac conduction disorders and cardiac dysrhythmias 0.145 0.097 - 0.205 
Claudication 0.016 0.008 - 0.028 
Heart failure: mild 0.037 0.021 - 0.058 
Heart failure: moderate 0.07 0.044 - 0.102 
Heart failure: severe 0.186 0.128 - 0.261 
Stroke: long-term consequences, mild 0.021 0.011 - 0.037 
Stroke: long-term consequences, moderate 0.076 0.050 - 0.110 
Stroke: long-term consequences, moderate plus cognition problems 0.312 0.211 - 0.433 
Stroke: long-term consequences, severe 0.539 0.363 - 0.705 
Stroke: long-term consequences, severe plus cognition problems 0.567 0.394 - 0.738 
Source: Murray, C. J., & Lopez, A. D. (2013). Measuring the global burden of disease. New England Journal of Medicine, 369(5), 448-457. 
 
Table A4. Mean (95% CI) of blood pressure trends (crude estimate) for the population aged 25 years and over in Thailand 
(mmHg). 
 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 
Male 121.3 121.3 121.2 121 120.9 120.9 120.8 120.8 120.9 121 
 
(112.3 
- 
130.3) 
(113.1 
- 
129.2) 
(113.8 
- 
128.2) 
(114.4 
- 
127.4) 
(114.9 
- 
126.7) 
(115.3 
- 
126.1) 
(115.7 
- 
125.7) 
(116.1 
- 
125.3) 
(116.5 
- 
125.2) 
(116.8 
- 
125.1) 
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Continued 
Female 116.6 116.7 116.8 116.9 117 117 117.1 117.2 117.3 117.4 
 
(107.6 
- 
126.0) 
(108.6 
- 
125.2) 
(109.4 
- 
124.4) 
(109.9 
- 
123.7) 
(110.7 
- 
123.2) 
(111.3 
- 
122.7) 
(111.7 
- 
122.3) 
(112.1 
- 
122.0) 
(112.6 
- 
121.8) 
(113.1 
- 
121.7) 
 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 
Male 121.1 121.3 121.5 121.7 121.9 122.2 122.4 122.6 122.8 122.9 
 
(117.1 
- 
125.2) 
(117.4 
- 
125.2) 
(117.7 
- 
125.3) 
(118.0 
- 
125.4) 
(118.3 
- 
125.6) 
(118.6 
- 
125.8) 
(118.9 
- 
126.1) 
(119.1 
- 
126.4) 
(119.2 
- 
126.4) 
(119.4 
- 
126.5) 
Female 117.6 117.8 117.9 118.1 118.4 118.6 118.8 133.9 119.1 119.3 
 
(113.5 
- 
121.6) 
(113.8 
- 
121.7) 
(114.2 
- 
121.7) 
(114.5 
- 
121.8) 
(114.8 
- 
121.9) 
(115.1 
- 
122.1) 
(115.4 
- 
122.2) 
(125.9 
- 
141.7) 
(115.8 
- 
122.5) 
(116.0 
- 
122.7) 
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Male 123.1 123.2 123.4 123.6 123.8 124.1 124.3 124.5 127.4 124.8 
 
(119.7 
- 
126.6) 
(119.9 
- 
126.7) 
(120.2 
- 
126.8) 
(120.5 
- 
126.9) 
(120.7 
- 
127.1) 
(120.9 
- 
127.3) 
(121.1 
- 
127.6) 
(121.1 
- 
128.0) 
(121.0 
- 
128.5) 
(120.6 
- 
129.1) 
Female 119.5 119.7 119.8 120 120.2 120.4 120.6 120.8 120.9 121 
 
(116.2 
- 
122.8) 
(116.5 
- 
122.8) 
(116.7 
- 
123.0) 
(116.8 
- 
123.2) 
(117.1 
- 
123.5) 
(117.2 
- 
123.8) 
(117.2 
- 
124.1) 
(117.1 
- 
124.5) 
(116.9 
- 
124.9) 
(116.6 
- 
125.4) 
 
Table A5. Mean (95% CI) of the total cholesterol trends (crude estimate) for population aged 25 years and over in Thailand 
(mmol/L). 
 1980 1981 1982 1983 1984 1985 1986 1987 1988 1989 
Male 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7 
 (3.9 - 5.4) (4.0 - 5.3) (4.0 - 5.3) (4.1 - 5.2) (4.1 - 5.2) (4.2 - 5.1) (4.3 - 5.1) (4.3 - 5.1) (4.3 - 5.0) (4.4 - 5.0) 
Female 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7 4.7 
 (3.8 - 5.6) (3.9 - 5.5) (3.9 - 5.4) (4.0 - 5.3) (4.1 - 5.3) (4.2 - 5.2) (4.2 - 5.2) (4.3 - 5.1) (4.3 - 5.1) (4.4 - 5.1) 
 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 
Male 4.7 4.7 4.8 4.8 4.8 4.8 4.8 4.9 4.9 4.9 
 (4.4 - 5.0) (4.5 - 5.0) (4.5 - 5.0) (4.5 - 5.0) (4.5 - 5.1) (4.6 - 5.1) (4.6 - 5.1) (4.6 - 5.1) (4.6 - 5.1) (4.6 - 5.1) 
Female 4.8 4.8 4.8 4.8 4.8 4.9 4.9 4.9 4.9 4.9 
 (4.4 - 5.1) (4.4 - 5.1) (4.5 - 5.1) (4.5 - 5.1) (4.5 - 5.2) (4.5 - 5.2) (4.6 - 5.2) (4.6 - 5.2) (4.6 - 5.3) (4.6 - 5.3) 
 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 
Male 4.4 4.3 5 5 5 5 5.1 5.1 5.1 5.2 
 (3.8 - 4.9) (3.8 - 4.9) (4.7 - 5.2) (4.8 - 5.2) (4.8 - 5.2) (4.8 - 5.3) (4.8 - 5.3) (4.9 - 5.3) (4.9 - 5.4) (4.5 - 5.4) 
Female 4.9 4.9 5 5.1 5.1 5.1 5.1 5.2 5.2 5.3 
 (4.7 - 5.2) (4.7 - 5.2) (4.7 - 5.3) (4.8 - 5.3) (4.8 - 5.4) (4.9 - 5.4) (4.9 - 5.4) (4.9 - 5.5) (4.9 - 5.5) (4.9 - 5.6) 
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Table A6. Average change in the level of risk factors between 1980 and 2009 in the Thai population who aged 25 years and over. 
Risk Factors 
Average change per year % Change between 1980 to 2009 
Male Female Male Female Total 
Blood pressure (mmHg) 6.1 4.3 2.9 3.8 3.35 
Total cholesterol (mmol/L) 0.4 0.5 10.6 12.8 11.70 
 
 
 
 
